Top Pharmaceutical Stocks for Q4 2021

2 years ago 298

IRWD is apical for worth and growth, and MRMD is apical for momentum

Updated September 14, 2021

The pharmaceutical manufacture is made of companies that research, develop, make, and merchantability drugs and treatments utilized to dainty oregon eradicate diseases, and vaccinate people. This includes immoderate of the largest and best-known companies successful the world, specified arsenic Pfizer Inc. (PFE), Merck & Co. Inc. (MRK), and AbbVie Inc. (ABBV). A fig of pharmaceutical companies, including Pfizer, person seen a surge successful their income aft winning support from U.S. and overseas governments for vaccines aimed astatine preventing the COVID-19 virus.

Over the past 12 months, pharmaceutical stocks, based connected the iShares U.S. Pharmaceuticals ETF (IHE), person lagged the show of the wide market. IHE's full instrumentality implicit the play was 19.3% compared to the Russell 1000's full instrumentality of 37.1%. These marketplace show figures and each statistic successful the tables beneath are arsenic of Sept. 10, 2021.

Here are the apical 3 pharmaceutical stocks with the champion value, the fastest growth, and the astir momentum.

Best Value Pharmaceutical Stocks

These are the pharmaceutical stocks with the lowest 12-month trailing price-to-earnings (P/E) ratio. Because profits tin beryllium returned to shareholders successful the signifier of dividends and buybacks, a debased P/E ratio shows you’re paying little for each dollar of nett generated.

Best Value Pharmaceutical Stocks
  Price ($) Market Cap ($B) 12-Month Trailing P/E Ratio
Ironwood Pharmaceuticals Inc. (IRWD) 12.20 2.0 3.9
Organon & Co. (OGN) 33.88 8.6 4.1
Collegium Pharmaceutical Inc. (COLL) 19.70 0.7 7.2

Source: YCharts

  • Ironwood Pharmaceuticals Inc.: Ironwood Pharmaceuticals develops and manufactures drugs utilized to dainty gastrointestinal and cardiovascular diseases.
  • Organon & Co.: Organon is simply a planetary women's healthcare institution that develops and produces medicines and different products crossed a scope of areas, including reproductive health, bosom disease, dermatology, allergies, and asthma. The institution announced successful mid-June that it has completed its acquisition of Alydia Health, a commercial-stage aesculapian instrumentality institution specializing successful the prevention of maternal morbidity and mortality caused by postpartum hemorrhage oregon abnormal postpartum uterine bleeding. Organon archetypal agreed to get Alydia Health successful March 2021 for $240 million.
  • Collegium Pharmaceutical Inc.: Collegium Pharmaceutical is simply a pharmaceutical institution specializing successful symptom management. It develops medications to dainty acute and chronic pain. The institution announced successful mid-August that its committee of directors authorized the repurchase of up to $100 cardinal of the company's communal stock. The timing and magnitude of share repurchases volition beryllium determined by management.

Fastest Growing Pharmaceutical Stocks

These are the apical pharmaceutical stocks arsenic ranked by a growth model that scores companies based connected a 50/50 weighting of their astir caller quarterly YOY percentage revenue growth and their astir caller quarterly YOY earnings-per-share (EPS) growth. Both income and net are captious factors successful the occurrence of a company. Therefore ranking companies by lone 1 maturation metric makes a ranking susceptible to the accounting anomalies of that 4th (such arsenic changes successful taxation instrumentality oregon restructuring costs) that whitethorn marque 1 oregon the different fig unrepresentative of the concern successful general. Companies with quarterly EPS oregon gross maturation of implicit 2,500% were excluded arsenic outliers.

Fastest Growing Pharmaceutical Stocks
  Price ($) Market Cap ($B) EPS Growth (%) Revenue Growth (%)
Ironwood Pharmaceuticals Inc. (IRWD) 12.20 2.0 1,390 16.3
Dynavax Technologies Corp. (DVAX) 17.55 2.0 N/A (see institution description) 1,880
BioDelivery Sciences International Inc. (BDSI) 4.28 0.4 800.0 13.3

Source: YCharts

  • Ironwood Pharmaceuticals Inc.: See supra for institution description.
  • Dynavax Technologies Corp.: Dynavax Technologies is simply a biopharmaceutical institution specializing successful processing immunotherapy treatments. It develops and commercializes caller vaccines and is collaborating with different biopharmaceutical companies to make vaccines to dainty COVID-19. Valneva SE (VLA), a France-based biotech institution moving connected a COVID-19 vaccine utilizing Dynavax's CpG 1018 arsenic an adjuvant, precocious received a termination announcement from the U.K. regarding Valneva's proviso statement for its COVID-19 vaccine candidate. Despite the termination, Valneva said that it would proceed moving connected its vaccine candidate. Dynavax said that its existent CpG 1018 proviso contracts inactive correspond a 2021 gross accidental of astir $300 to $400 million. Because the company's EPS went from antagonistic successful the year-ago 4th to affirmative successful the astir caller quarter, an EPS maturation complaint could not beryllium calculated for the array above.
  • BioDelivery Sciences International Inc.: BioDelivery Sciences International is simply a pharmaceutical institution specializing successful innovative therapies for patients that person superior and debilitating chronic conditions, including chronic symptom and acute migraine. The institution precocious announced that it completed the acquisition of U.S. and Canadian rights to ELYXYB, the lone FDA-approved, ready-to-use oral solution for the acute attraction of migraine successful adults. The seller was Doctor Reddy's Laboratories Ltd. (DRREDDY). The full worth of the transaction, which was archetypal announced successful aboriginal August 2021, was $15 million.

Pharmaceutical Stocks with the Most Momentum

These are the pharmaceutical stocks that had the highest full instrumentality implicit the past 12 months.

Pharmaceutical Stocks with the Most Momentum
  Price ($) Market Cap ($M) 12-Month Trailing Total Return (%)
MariMed Inc. (MRMD) 1.00 327.5 521.9
22nd Century Group Inc. (XXII) 3.23 525.6 442.8
Zomedica Corp. (ZOM) 0.60 583.6 440.6
Russell 1000 N/A N/A 37.1
iShares U.S. Pharmaceuticals ETF (IHE) N/A N/A 19.3

Source: YCharts

  • MariMed Inc.: MariMed is simply a cannabis and hemp company. It offers a afloat scope of cannabis products, including branded products for the attraction of circumstantial aesculapian symptoms. The institution operates cannabis facilities and dispensaries successful aggregate states.
  • 22nd Century Group Inc.: 22nd Century Group is simply a works biotechnology company. It uses familial engineering and works breeding to change the nicotine contented successful baccy plants and cannabinoids successful cannabis plants.
  • Zomedica Corp.: Zomedica is simply a veterinary wellness company. It is moving connected processing a point-of-care diagnostic level based connected exertion designed to observe pathogens successful companion animals.

The comments, opinions and analyses expressed herein are for informational purposes lone and should not beryllium considered idiosyncratic concern proposal oregon recommendations to put successful immoderate information oregon to follow immoderate concern strategy. While we judge the accusation provided herein is reliable, we bash not warrant its accuracy oregon completeness. The views and strategies described connected our contented whitethorn not beryllium suitable for each investors. Because marketplace and economical conditions are taxable to accelerated change, each comments, opinions, and analyses contained wrong our contented are rendered arsenic of the day of the posting and whitethorn alteration without notice. The worldly is not intended arsenic a implicit investigation of each worldly information regarding immoderate country, region, market, industry, investment, oregon strategy.

Article Sources

Investopedia requires writers to usage superior sources to enactment their work. These see achromatic papers, authorities data, archetypal reporting, and interviews with manufacture experts. We besides notation archetypal probe from different reputable publishers wherever appropriate. You tin larn much astir the standards we travel successful producing accurate, unbiased contented successful our editorial policy.

Read Entire Article